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A B S T R A C T
We have, in previous work developed, characterized and evaluated the biocompatibility of an engineered
hyaluronic acid nanogel. Here we assess the targetability of a hyaluronic acid nanogel towards CD44
overexpressing cells, in vitro and in vivo. Results obtained by ﬂow cytometry and confocal ﬂuorescence
microscopy shows that nanogel is greatly internalized by non-small cancer lung cells (A549 cells), that
overexpress CD44 receptors. The biodistribution and tumor targetability of the nanogel labelled with a near-
infrared (NIR) probe were performed, in mice, through a non-invasive imaging system. Results revealed nanogel
high targetability towards an induced subcutaneous A549 tumor. Nanogels pharmacokinetics was evaluated also
in healthy animals, and Alexa Fluor 680 labelled nanogel exhibited higher accumulation in liver, kidneys and
skin. Also, a comparative biodistribution study was performed, using two NIR imaging probes, Cy5.5 and Alexa
Fluor 680.
1. Introduction
Hyaluronic acid is a naturally occurring polysaccharide, ubiquitous
in the human body, widely used in biomedical applications as a
conjugate, hydrogel, nanogel and many other applications.
Hyaluronic acid demonstrates appealing biological properties such as,
biocompatibility, biodegradability and non-antigenic (Arpicco et al.,
2014). Among the most attractive features of hyaluronic acid applied to
nanomaterials is its potential for active targeting (Goodarzi et al.,
2013). The strong aﬃnity of hyaluronic acid for cell surface receptors,
namely CD44 and Receptor for Hyaluronan Mediated Motility
(RHAMM), has been demonstrated (Goodarzi et al., 2013; Platt and
Szoka, 2008). The CD44 receptor is a glycoprotein overexpressed in the
cell membrane of numerous cancer cells and important in the metas-
tization process (Arpicco et al., 2014; Goodarzi et al., 2013). We have
developed a hyaluronic acid nanogel by grafting a thiolated hydro-
phobic chain in the polysaccharide backbone. The amphiphilic con-
jugate self assembles in aqueous environment onto nanostructures. The
nanogel has already proven to be crosslinkable by disulﬁde bond and its
physicochemical characterization has already been addressed (Pedrosa
et al., 2014). Also, in vitro and in vivo biocompatibility of the engineered
nanogel has also been demonstrated (in press). In this work, we intend
to assess the nanogel targetability mediated by hyaluronic acid inter-
face towards CD44 overexpressing cancer cells. Non-small cancer lung
cells – A549 cell line – express high levels of CD44 receptors (Arpicco
et al., 2014; Ganesh et al., 2013) and therefore, were used as a target for
nanogel uptake studies. The in vitro cellular uptake of nanogel by A549
cells was assessed by ﬂow cytometry analysis and confocal ﬂuorescence
microscopy. Also, we investigated the nanogel targetability in tumor
bearing mice - induced with subcutaneous A549 cells tumor. The
biodistribution was analysed in a non-invasive real time NIR imaging
system, after intravenous administration of probe labelled samples. NIR
probes have the advantage of high depth penetration, high ﬂuorescence
intensity and amenable self-quenching (Ogawa et al., 2009). Studies
have shown that changes in particle size, surface charge, texture and
heterogeneity in nanoparticles formulation inﬂuence its biodistribution
(Adjei et al., 2014). Therefore, we also performed a comparative study
of in vivo pharmacokinetics of the HyA nanogel, native HyA and free
probe in healthy animals, using two diﬀerent NIR probes, namely Cy5.5
and Alexa Fluor 680.
2. Materials
Sodium hyaluronate (MW.7.46 kDa) was purchased from Lifecore
Biomedical (USA). 1-ethyl-3-[3 dimethylaminopropyl]carbodiimide
hydrochloride (EDC), cysteamine hydrochloride, trypan blue, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), hydro-
gen nicotinamide adenine dinucleotide (NADH) and pyruvate were
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purchased from Sigma-Aldrich (Italy).
Cy 5.5 hydrazide was purchased from GE Healthcare (UK).
Fluorescein-5-thiosemicarbazide and Alexa Fluor 680 C2 maleimide
acquired from Thermo Fisher Scientiﬁc/Life Technologies (USA).
Cell Culture materials were purchased from Biochrom (Germany).
Animals were acquired from Charles River (Germany) and main-
tained in Molecular Medicine Institute (Lisbon) Rodents Facility.
3. Methods
3.1. Cell lines and cell culture
Human alveolar adenocarcinoma cells (A549) were maintained in
Dulbecco's Modiﬁed Eagle's Media (DMEM) supplemented with 10% (v/
v) of heat-inactivated foetal bovine serum (FBS), 100 IU/ml penicillin
and 0.1 mg/ml streptomycin. Cystic ﬁbrosis bronchial epithelial cells
(CFBE) were cultured in Roswell Park Memorial Institute (RPMI) 1640
Medium supplemented with 10% (v/v) of heat-inactivated FBS, peni-
cillin and streptomycin. The cells were maintained as a subconﬂuent
monolayer in a humidiﬁed atmosphere containing 5% CO2 at 37 °C.
3.2. In vitro cell toxicity
Nanogel toxicity in A549 cell line was assessed through 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) reduc-
tion assay (Mosmann, 1983) and lactate dehydrogenase (LDH) release
assay (Fotakis and Timbrell, 2006).
3.2.1. Cell proliferation assay
A549 cells were seeded in 24-well cell culture plates at a density of
1 × 104 cells per well and left adhering in 0.5 ml of adequate culture
medium overnight. HyA-AT nanogel 0.1 mg/ml, 0.5 mg/ml and 1 mg/
ml dispersions were suspended in adequate culture medium, resulting
in a 1:5 fresh medium dilution. Untreated cells were used as control of
100% cell viability and 20% distilled water control was used to access
the eﬀect of water dilution of samples containing the nanogel. A
positive control with 20% of DMSO was used in every analysis. The
samples were incubated for 24, 48 and 72 h and the cells metabolic
activity is calculated due to the reduction of tetrazolium salt of MTT by
mitochondrial succinate dehydrogenase enzymes of metabolically
active cells. To which well, 10% (v/v) of a MTT solution (5 mg/ml in
PBS) was added and it was incubated at 37 °C and 5% CO2 for a period
of 4 h. In this period of time, the tetrazolium salt is bioreduced to a
formazan product that consists in is dark blue crystals that are insoluble
in the culture medium. The supernatant was discarded slowly and the
crystals were solubilized in dimethyl sulfoxide and quantiﬁed spectro-
photometrically at 570 nm. The experiments were performed in tripli-
cates as the results are presented as percentage in which 100% viability
corresponds to the non-treated cells.
3.2.2. LDH release assay
Cells were seeded in 12-well plate at a density of the 2 × 105 cells
per well and allowed to settle overnight in 0.5 ml of adequate culture
medium. Then, cells were treated with nanogel dispersions with a
concentration of 0.1 and 1.0 mg/ml in suitable culture medium and
supplementation. Untreated cells were used as control of 100% cell
viability. Another control with 20% distilled water was used to access
the eﬀect of the water dilution of the samples containing the nanogel. A
control with 20% of DMSO was used in every analysis as a positive
control. The samples where incubated for 24 h and after that period
each culture medium from every well was collected and centrifuged at
13000 rpm for 1 min and the cell free supernatant was collected and
stored on ice for further analysis – extracellular LDH. Cells were scraped
with a Tris solution (15 mM) extracellular and further lysed by
sonication. The resulting supernatants were used to quantify the LDH
present – Intracellular LDH. An aliquot of extracellular (40 μl) or
intracellular (10 μl) LDH were assigned into a microplate and 250 μl
of the NADH solution 0.31 mM in phosphate buﬀer 0.05 M, pH 7.4
added to each well. Lastly, 10 μl of an 8.96 mM piruvate solution in
phosphate buﬀer (substrate solution) was added and immediately
afterwards the variation of the absorbance at 340 nm was read in a
microplate spectrophotometer system, as to determine the rate of
NADH consumption (slope of the line). LDH leakage was expressed as
the ratio between extracellular and total LDH, corresponding the
inverse value to the cell membrane integrity. Each experiment was
performed in triplicate.
3.3. In vitro cellular uptake
The cellular uptake was evaluated by ﬂow cytometry (FCM)
analysis, confocal ﬂuorescence microscopy and trypan blue exclusion
assays.
3.3.1. Synthesis of ﬂuorescein labelled nanogel
Hyaluronic acid nanogel (HyA-AT) synthesis was described else-
where (Pedrosa et al., 2014). HyA-AT nanogel was conjugated with
ﬂuorescein-5-thiosemicarbazide for in vitro cellular studies. Thiosemi-
carbazide group of the probe reacted with carboxylic group of
hyaluronic acid nanogel in presence of EDC as a coupling agent. The
theoretical labelling degree, deﬁned by the ratio between probe and the
nanogel, was 0.25. The lack of unconjugated ﬂuorescein was conﬁrmed
by ultraﬁltration through a 2 kDa MW cut-oﬀ membrane. In ﬁltrate and
concentrate, probe emission was measured spectrophotometrically and
the absence of ﬂuorescence signal was achieved in the last ﬁltrate
(Hermanson, 2008; Tanzer et al., 1966).
3.3.2. Flow cytometry analysis
Quantitative cellular uptake of nanogel in CD44 expressing (A549)
and non-expressing cells (CFBE) was conducted in a Coulter Epics XL
Flow Cytometer (Beckman Coulter Inc., Miami, FL, USA). Cells were
seeded in 24-well plates at 1.0 × 105 density and incubated overnight
to allow attachment. Culture medium was removed and A549 cells were
incubated with culture medium containing 0.2 mg/ml and 0.5 mg/ml
of HyA-AT nanogel, for designated time intervals. Then, CFBE cells
were processed similarly using a concentration of 0.5 mg/ml of
nanogel. After 0 and 30 min, 1, 2, 3, 5, 7 and 24 h, culture medium
was removed and cells were rinsed with PBS. Cells were then harvested
by trypsinization, collected with FBS supplemented culture medium
and centrifuged at 300g for 10 min. Supernatant was rejected and cells
were washed with PBS twice and ﬁnally resuspended in ﬂow cytometry
staining buﬀer prior to analysis. Cells were gated based on size vs
granularity (Forward Scattered/Side Scattered, FSC/SSC) dot plots. The
ﬂuorescence due to nanogel internalization was evaluated in FL1 (green
channel), where FL1 positive cells had internalized/adhered nanogel.
Cell count was set to minimum 20,000 events. Results are expressed as
mean ﬂuorescence intensity and the frequencies (or percentage) of cells
in gates of interest (n= 5).
3.3.2.1. Trypan blue exclusion assay. Trypan blue (TB) is a cell
impermeable dye. The exclusion assay is based on the capability of
TB to quench green ﬂuorescence (FITC/ﬂuorescein) signal at the cell
surface (Vranic et al., 2013; Avelar-Freitas et al., 2014; Keogh et al.,
2011). Therefore, TB assay allows us to distinguish between
internalized and cell adhering nanogel (Vranic et al., 2013; Gratton
et al., 2008). Samples, after being analysed were further incubated with
0.1% trypan blue for 1 min. Cellular debris and aggregates were
excluded by FSC/SSC gating and results were analysed in FL1/FL3
(green/red channels). Results are expressed as mean ﬂuorescence
intensity of the FL1 signal (n= 5).
3.3.3. Confocal ﬂuorescence microscopy
Cellular uptake of HyA-AT nanogel labelled with ﬂuorescein was
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evaluated in CD44 overexpressing cells – A549 cells (McDonald et al.,
2008; Roudi et al., 2014; Zhang et al., 2010) and other lung cell line
that does not overexpress CD44 receptors – CFBE (Reeves et al., 2011;
Reeves et al., 2010; Vandivier et al., 2009).
Cells were seeded on coverslip discs in 24 well plates at 5 × 105
cells/well density. HyA-At-ﬂuorescein (0.2 mg/ml concentration) was
incubated with cells for 7 min adequate culture medium and atmo-
sphere conditions. To further assess if the nanogel uptake was mediated
by hyaluronic acid receptors, we performed a competitive study with
free hyaluronic acid, in A549 cells. So, we pre-incubated A549 cells
with 10 mg/ml free HyA dispersed in culture medium, for 1 h prior to
nanogel addition. The culture medium was removed and replaced with
0.2 mg/ml of nanogel, and incubated for 7 h. Then, medium was
removed and cells were rinsed twice with PBS and ﬁxed with a 2%
para-formaldehyde solution (in PBS). After 20 min, cells were again
washed twice with cold PBS. Cell nucleus were stained with 4′,6-
diamidino-2-phenylindole (DAPI, 120 ng/ml) for 3 min at room tem-
perature. Cell seeded coverslips were observed in a confocal laser
scanning microscope Leica SP2 AOBS SE (Leica Mycrosystems,
Germany).(Avelar-Freitas et al., 2014; Gratton et al., 2008).
3.4. In vivo spectral imaging studies
3.4.1. Animals and treatments
All animal experiments were performed in compliance with the
Portuguese General alimentary and Veterinarian Board (authorization
number 006315/27/03/2014, from DGAV-Portugal) and animals were
kept and used strictly in accordance with National rules and the
European Communities Council Directive (86/609/EEC), for the care
and handling of laboratory animals. Balb/cByJ 6-week old male mice
and CD1 nude crl: CD1nude 6-week old mice were acquired from
Charles River (Germany) and maintained in Molecular Medicine
Institute (Lisbon) Rodents Facility. Animals were divided into groups
(n= 5), for diﬀerent time point analysis and samples administration.
The following samples were tested: nanogels HyA-AT-Cy5.5 and HyA-
AT-Alexa680; native HyA-Cy5.5 and HyA-Alexa680; free Cy 5.5 and
Alexa680. The labelled nanogels (HyA-AT-Cy5.5 and HyA-AT-
Alexa680) were dispersed in saline solution and ﬁltered through
cellulose acetate syringe ﬁlter (pore size 0.22 μm) in aseptic conditions
and its size distribution analysed by DLS. All the samples were
administered intravenously through the tail vein at 5 mg/kg body
weight, as described by several authors (Choi et al., 2010; Choi et al.,
2011; Yoon et al., 2013). Samples labelling intensity was compared by
UV/Vis spectroscopy at probes maximum excitation wavelength to
compare their intensity.
3.4.2. Synthesis of Alexa Fluor labelled hyaluronic acid and hyaluronic
acid nanogel
Alexa Fluor 680 C2 maleimide is a thiol reactive conjugate used for
NIR probing. Maleimide undergoes an alkylation reaction with sulfhy-
dryl groups to form a thioether bond (Nobs et al., 2003). HyA-AT
nanogel is a thiolated hyaluronic acid conjugate and therefore, its thiol
group reacts directly with maleimide moiety of the probe. Native
hyaluronic acid had to be modiﬁed to become reactive towards the
maleimide reactive probe. Therefore, similarly to the nanogel synthesis
(Pedrosa et al., 2014) cysteamine hydrochloride was grafted by amide
bond formation to the carboxylic acid residue of native hyaluronic acid.
In brief, HyA-TBA salt was dissolved in DMSO and reacted with
cysteamine hydrochloride (2:1) in presence of EDC and NHS (equimolar
amounts). The solution was dialysed against a NaCl solution and then
dH2O and lyophilized. Resulting thiolated native HyA was conjugated
with the probe by the same chemistry.
Hence, 10 mg of nanogel and native HyA reacted with 0.4 mg (2%
theoretical labelling) of Alexa Fuor 680 C2 maleimide in 0.1 M PBS
solution (pH 7.4). Reaction was allowed to occur overnight at room
temperature and protected from light. Afterwards, solutions were
dialysed through a 2 kDa cutoﬀ membrane to remove the unreacted
probe. Conﬁrmation was obtained by ultraﬁltration and UV/VIS
analysis of the solutions collected from the upper and lower compart-
ments. Samples were analysed spectrophotometrically at 679 nm.
(Gruber et al., 2000) (Hermanson, 2008; Bae et al., 2009; Bae et al.,
2008).
3.4.3. Synthesis of cyanine (Cy 5.5) labelled hyaluronic acid and
hyaluronic acid nanogel
HyA nanogel and native HyA were labelled with Cy 5.5 – hydrazide.
Hydrazide reactive moiety was conjugated with carboxylic groups of
HyA-AT nanogel (Hermanson, 2008; Ahn et al., 1987; Na et al., 2007;
Luo and Prestwich, 1999) in presence of EDC, as coupling agent. The
molar ratio of Cy 5.5 – hydrazide to free carboxylic groups of HyA-AT
nanogel and native HyA was 0.25. EDC was also added at an equimolar
ratio to the free carboxylic acid groups of HyA-AT nanogel. The reaction
was allowed to occur overnight at room temperature, in the dark. The
reaction mixture was thoroughly dialysed (MW cut-oﬀ 2000 Da) against
distilled water to remove non-desired reaction products. Also, the
absence of unconjugated dye was conﬁrmed by ultraﬁltration through
a 2 kDa MW cut-oﬀ membrane. Samples labelling was assessed spectro-
photometrically at 649 nm. Samples labelling was assessed spectro-
photometrically at 649 nm. (Ogawa et al., 2009; Berlier et al., 2003)
(Ilgin et al., 2010; Kadi et al., 2009).
3.4.4. Comparison of pharmacokinetics of Cy5.5 and Alexa Fluor 680
To evaluate the possible diﬀerences in biodistribution proﬁle of
nanogel when labelled with chemically diﬀerent NIRF probes, two
probes were analysed – Cy 5.5 and Alexa680. Therefore, HyA-AT
nanogel and native HyA were labelled with Cy5.5 hydrazide or
Alexa680. Free probe was also analysed to infer its in vivo biodistribu-
tion proﬁle. Samples were administrated to BALB/c mice at 5 mg/kg
BW through the tail vein. At established intervals (20 min, 2, 7, 24 and
48 h) mice were anesthetised with ketamine/medetomidine and whole
body NIR ﬂuorescence images were acquired. At the ﬁnal time point
(48 h after sample administration) animals were sacriﬁced and major
organs - liver, lung, spleen, kidney, skin, muscle, heart and brain -, and
also blood samples were collected for analysis. NIRF images of dissected
organs and blood were obtained and ﬂuorescence intensity quantiﬁed
by ROI measurement. In vivo real time NIR ﬂuorescence images of the
animas were acquired in a Xenogen's IVIS® Lumina Series and Living
Image® Software. Imaging was obtained under the following settings:
excitation passband of 615–665 nm and emission passband of 695–770
wavelength; exposure time was set to 1 s, pixel binning medium and
lens aperture (f/stop) 16.
All values are presented as average ﬂuorescence intensity (p/s/cm2/
sr) ± SD for n= 5 animals.
3.4.5. Study of in vivo nanogel pharmacokinetics in healthy animals
We proposed to assess HyA-AT nanogel biodistribution proﬁle in
comparison to native HyA after intravenous administration, using free
NIR ﬂuorescent probe as control. BALB/c mice were injected in the tail
vein with Alexa680 labelled HyA-AT nanogel (HyA-AT-Alexa680) and
native HyA (HyA-Alexa680) at 5 mg/kg BW. At established time points
– 5 min, 1, 8, 24 and 48 h – animals (n= 5) were anesthetised to
remain immobile with ketamine 75 mg/kg BW and medetomidine
1 mg/kg BW intraperitoneally. In vivo real time NIR ﬂuorescence
images of the animas were acquired in a Xenogen's IVIS® Lumina
Series and Living Image® Software. After, whole blood was harvested by
cardiac puncture and ex vivo organ collection was performed. Major
organs - liver, lung, spleen, kidney, skin, muscle, heart and brain - were
collected and further analysed. NIRF images of dissected organs and
blood were obtained, and ﬂuorescence intensity quantiﬁed by ROI
measurement. All values are presented as average ﬂuorescence inten-
sity (p/s/cm2/sr) ± SD for n= 5 animals.
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3.4.6. Study of nanogel targetability in tumor xenograft animals
In vivo tumor targetability of HyA-AT nanogel was assessed in CD1
nude mice with A549 subcutaneous induced tumor. With that intent,
HyA-AT nanogel and also native HyA, as a control, were labelled with
Alexa Fluor 680. The animal model chosen was Crl: CD1-Foxn1nu mice,
due to the lack of thymus once we intended to induce a subcutaneous
xenograft tumor. Approximately 5 × 106 A549 cells were suspended in
100 μl of saline physiological and Matrigel (BD Biosciences, CA, USA)
and were subcutaneously injected into dorsa right side of mice (Ganesh
et al., 2013; Choi et al., 2010; Choi et al., 2011; Abbad et al., 2015).
Tumor mass was monitored periodically with a caliper and was
calculated as V = 1/2 (length × width2). Animals were used in experi-
ment when tumors size reached approximately 100 mm3. As in previous
section, HyA-AT-Alexa680 and HyA-Alexa680 labelled materials were
administered and at the following time points animals were analysed:
5 min, 1, 8, 24 and 48 h (n= 5). Prior to image acquisition animals
were anesthetised with ketamine/medetomidine combination. After the
whole body in vivo image acquisition, whole blood was harvested by
cardiac puncture and ex vivo organ collection was performed. Major
organs - liver, lung, spleen, kidney, skin, muscle, heart and brain -, also
the tumor mass were collected and further analysed. NIRF images of
dissected organs, blood and tumor were obtained and ﬂuorescence
intensity quantiﬁed by ROI measurement. All values are presented as
average ﬂuorescence intensity (p/s/cm2/sr) ± SD for n= 5 animals.
3.4.7. Ex vivo tissue distribution
Soon after NIR ﬂuorescence images of mice whole body were
obtained, animal's whole blood was collected through cardiac puncture.
After, animals were euthanized with a lethal dose of anaesthesia and
major organs were collected - liver, lung, spleen, kidney, skin, muscle,
heart and brain – and tumor (in tumor targetability assay). Herein, NIR
ﬂuorescence images of dissected organs and blood were obtained in the
same IVIS® Lumina equipment and ﬂuorescence intensity quantiﬁed by
ROI measurement. Similar parameters were applied in this analysis as
the described in prior section. All values are presented as average
ﬂuorescence intensity (p/s/cm2/sr) ± SD for n= 5 animals.
3.5. Statistical analysis
The results were expressed as mean ± SD of 3 independent
experiments (n= 5). Statistical analysis was performed with t-test or
two-way ANOVA followed by Tukey's comparison test using using
GraphPad Prism version 6.00 for Mac OS X, GraphPad Software, La
Jolla, California, USA. Signiﬁcance of the results is indicated according
to P values with one, two, three or four of the used symbols (*, # or +)
corresponding to P= 0.01 to 0.05; P= 0.001 to 0.01; P= 0.0001 to
0.001 and P < 0.0001, respectively).
4. Results and discussion
4.1. In vitro cell toxicity
Cell proliferation assay using MTT is a colorimetric, easy, fast and
safe assay that measures the mitochondrial metabolic activity of viable
cells. In Fig. 1a, we observed that the control with 20% water dilution
presented a slightly lower cell growth or activity may be due to the
dilution of nutrients of the culture medium. This eﬀect was most
noticed in the longer incubation time (72 h).
Cells metabolic activity was not overall aﬀected by the nanogel
presence in comparison to the water diluted control. However, at
highest incubation time (72 h) and nanogel concentration (1 mg/ml) a
signiﬁcative diﬀerence was observed (Fig. 1a). A549 cell line is a
human pulmonary adenocarcinoma cell line that overexpresses CD44
receptors - a hyaluronic acid receptor. Therefore, it may be speculated
that these receptors mediate a signiﬁcant nanogel uptake. However, we
must mention that the highest concentration tested (1 mg/ml) is very
high, with the intention of really testing the limits of toxicity.
The evaluation of cell membrane integrity was performed by LDH
release assay. As shown in Fig. 1b, membrane integrity was preserved at
all nanogel concentrations.
Cells were exposure to HyA-AT nanogel at 0.1 to 1 mg/ml concen-
tration. Non-treated cells referred to as culture medium are considered
100% cell viability at 72 h. Statistical analysis was performed using a
two-way ANOVA and a Tukey's comparison test. Diﬀerences between
samples and culture medium at any given time point are represented by
(*); whereas diﬀerences between samples and 20% dH2O dilution
control at any given time point are represented by (#); diﬀerences
between nanogel concentration are represented by (+).
4.2. In vitro cellular uptake
We aim to demonstrate HyA nanogel's ability to actively target cell
receptors such as CD44 and RHAMM, overexpressed in numerous tumor
cells. (McDonald et al., 2008; Choi et al., 2010; Abbad et al., 2015; Li
et al., 2014; Leung et al., 2010). Therefore, we studied the nanogel
Fig. 1. Nanogel cytotoxic eﬀect on A549 cells was determined by MTT and LDH release
assays. a) Cell viability was evaluated by MTT assay at 24, 48 and 72 h and; b) cell
membrane integrity by LDH release assay, at 24 h incubation time.
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cellular uptake by A549 human non-small cancer lung cells that
overexpress CD44 receptors. Also, cellular uptake was compared to
CFBE cells, also obtained from pulmonary tissue (human cystic
ﬁbrosis), that do not overexpress those receptors (Reeves et al., 2011;
Reeves et al., 2010; Vandivier et al., 2009).
Hence, A549 cells were treated with two nanogel concentrations
(0.2 mg/ml and 0.5 mg/ml) to evaluate the dose eﬀect on the inter-
nalization kinetics. In Fig. 2a, b, and d, we can see the nanogel uptake
was dose dependent at almost all points, and ﬂuorescence intensity was
double.
We also analysed the nanogel uptake in CFBE cells (Fig. 2c).
Although testing only the highest nanogel dosage we can see that
MFI values were much lower than those obtained with A549 cells using
similar conditions.
The TB exclusion assay makes it possible to distinguish between cell
adhering and cell internalized nanogel particles. Trypan blue is a cell
impermeable dye able to quench ﬂuorescence signal originated from
nanogel adhered to the cell surface (Vranic et al., 2013; Avelar-Freitas
et al., 2014; Van Amersfoort and Van Strijp, 1994). Results of TB
quenching, show that around 20–50% of the nanogel detected was not
internalized (Fig. 2a, b and c).
An interesting feature of the internalization process in A549 cells
concerns is its kinetics. As observed after quenching of membrane
adherent nanogel in A549 cells, the rate of internalization was initially
slow, and then accelerated considerably. This eﬀect was more evident
at the lowest dosage of nanogel.
Indeed, it has been reported that hyaluronic acid nanoparticles
uptake by CD44 expressing cells may take 20–30 min (Schuldt, 2000;
Scarselli and Donaldson, 2009) or up to 1 h (Zaki et al., 2011).
A comparative analysis of nanogel uptake in A549 and CFBE cells,
after TB quenching revealed (Fig. 2e) a higher nanogel uptake in A549
cells, persuading us to think that nanogel uptake in these cells is
mediated by HyA receptors and, probably by CD44 receptors – over-
expressed in these cells.
Confocal microscopy analysis of nanogel internalization was also
performed in A549 and CFBE cells, qualitatively corroborating the FCM
results. In Fig. 3, we can see much brighter green ﬂuorescence signals in
the cytoplasm of A549 cells than, under the same conditions, in CFBE
cells. To evaluate the mechanism of cellular uptake, a competitive study
in which, A549 cells were treated with an excess of free HyA, 1 h before
nanogel incubation was performed. As expected, ﬂuorescence in HyA-
treated A549 cells decreased substantially in comparison to non-treated
cells. This result suggests that native HyA, may be interacting with cell
HyA receptors – probably CD44 receptors - and inhibiting nangoel
internalization by competitive cellular uptake.
5. In vivo imaging studies
5.1. Nanogel labelling and characterization
In order to evaluate the biodistribution proﬁle of HyA-AT nanogel,
Alexa680 and Cy5.5 were chemically conjugated to nanogel and native
HyA (Fig. 4). Also, the biodistribution of each probe was analysed, to
evaluate whether it bears speciﬁc aﬃnity for a speciﬁc tissue. The
obtained nanogel- probe conjugates were characterized regarding their
size distribution proﬁle, by DLS (Fig. 4). For biodistribution studies
near-infrared (NIR) probes are a pertinent choice due to deep tissue
penetration, high ﬂuorescence signal and amenable self-quenching
(Ogawa et al., 2009). Cyanine dyes, and in particular 5.5, has shown
high background ﬂuorescence, high plasma protein binding and
undesired aggregation. In turn, Alexa680 has higher excitation/emis-
sion threshold and therefore less background, being less sensitive to
photobleaching (Luo et al., 2011; Yang et al., 2010).
5.2. Comparison of Alexa Fluor 680 and Cy 5.5 pharmacokinetics in
healthy mice
Changes in size, surface charge, texture and heterogeneity in
nanoparticles formulation are known to inﬂuence their biodistribution
(Adjei et al., 2014). As shown in Fig. 4, the mean size diameter of the
nanogel-probe conjugates was slightly higher in the nanogel-Cy5.5
conjugate. The zeta potential was also measured in the nanogels
decorated with the probes and values of −28.7 mV ± 1.99 mV
(Cy5.5), and −18.9 ± 1.87 mV (Alexa680) were obtained. The origi-
nal – non-labelled – nanogel zeta potential is −19.3 ± 1.97 mV
(Pedrosa et al., 2014). So it was not strange to see that, Cy5.5
conjugation increased somewhat the zeta potential of the nanogel,
owing to its negative charge. Alexa680, on the other hand is a smaller,
non-charged molecule (Fig. 4). The eﬀect on the zeta potential suggests
that the grafted Cy5.5 molecule, which reacts with the HyA carboxylic
groups, is displayed on the nanogel surface. The Alexa680 grafting took
place in the sulfhydryl residues of the hydrophobic chain of the nanogel
and, also because of its lipophilicity, this probe may likely be lodged in
nanogel hydrophobic domains. Since we could not ﬁnd Alexa Fluor
dyes reactive towards carboxylic groups, such as in the case of Cy5.5,
we could not compare the two probes grafted using the same chemistry.
We studied the biodistribution of nanogel labelled with two
diﬀerent probes and as a control, native HyA and free probe. As can
be seen in Fig. 5.Ia and .IIa, even after 48 h there was higher NIR
background signal in Cy5.5 treated animals than in Alexa680 treated
animals. In the later, signal was more concentrated and not spread in
the whole body as seen for Cy5.5. The ex vivo images (Fig. 5.IIb) of
major organs collected 48 h post-administration, revealed that Cy5.5
labelled samples showed a higher accumulation in lung, kidneys and
skin, whereas, Alexa680 samples were mostly distributed to liver,
kidneys and skin (Fig. 5.Ib). Adjei et al., 2014 compared the biodis-
tribution proﬁle of large anionic as opposed to small neutral, PLGA
nanoparticles. They reported that large anionic NPs showed greater
accumulation in the reticuloendothelial system, such as the liver and
spleen, whereas small neutral NPs, showed accumulation in highly
vascularized organs, such as the lungs, the kidneys and the heart.
However, the mechanism throughout this occurs is yet to be proven. It
is well established that the properties of the NPs interface inﬂuence
protein binding and therefore their behaviour in vivo (Gref et al., 2000).
One may speculate that the NIR probes can cause diﬀerent protein
corona in vivo upon entering the circulatory system and therefore aﬀect,
the organ distribution and accumulation. It has been reported that
higher liver, spleen and bone marrow uptake is largely attributed to
macrophages uptake. The serum proteins that compose the protein
corona of nanomaterials are responsible for the recognition by the
scavenger receptors of the macrophages (Kumar et al., 2010). Note-
worthy is the fact that, for both probes, a low spleen accumulation was
observed. Other researchers have also found a preferable lung accu-
mulation when using Cy5.5 as NIR probe for pharmacokinetics studies.
Hue et al., 2013 studied the ex vivo kinetic of free Cy5.5, and Cy5.5
labelled thermally cross-linked superparamagnetic iron oxide nanopar-
Fig. 2. Flow cytometry analysis of ﬂuorescein labelled HyA-AT nanogel uptake a) Mean ﬂuorescence intensity (MFI) observed on A549 cells along with the incubation time after
incubation with nanogel (0.2 mg/ml), with and without trypan blue (TB) treatment and; b) Mean ﬂuorescence intensity (MFI) observed on A549 cells along with the incubation time after
incubation with nanogel (0.5 mg/ml), with and without trypan blue (TB) treatment; c) Mean ﬂuorescence intensity (MFI) observed on CFBE cells along with the incubation time after
incubation with nanogel (0.5 mg/ml), with and without trypan blue (TB) treatment; d) Comparison of the nanogel internalization in A549 cells, using two nanogel concentrations –
0.2 mg/ml and 0.5 mg/ml – with and without TB quenching assay; e) Comparison of the nanogel internalization in A549 and CFBE cells after incubation with the same dosage of nanogel
– 0.5 mg/ml – after TB treatment. Results are presented as MFI ± SD, n= 5. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version
of this article.)
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ticles. Cy5.5 dye ﬂuorescence in the body was rapidly eliminated,
although high ﬂuorescence intensity was observed in the lungs, kidneys
and also liver. Thermally cross-linked superparamagnetic iron oxide
nanoparticles labelled with Cy5.5, had the highest ﬂuorescence inten-
sity in the lungs at earlier times and decreased over time, until 28 days.
Other researchers (Lee et al., 2012), have found that 7 h after
administration Cy5.5 N-hydroxysuccinimide ester accumulated in the
lungs and liver, and Cy5.5-conjugated ZnO nanoparticles showed strong
signal in the kidneys and liver. Others researchers had encountered
lung accumulation of nanoparticles when using Cy5.5 probe (Lee et al.,
2007; Iqbal et al., 2010). Alexa680 biodistribution is at the moment not
much studied and therefore, information regarding its pharmacoki-
netics is yet insuﬃcient. Given the diﬀerential biodistribution of the
nanogels labelled with the two NIR probes, it may be concluded that at
least one of the probes inﬂuences the results obtained. Considering the
published evidence suggesting that Cy5.5 exhibits some trend towards
concentration in the lung, and the fact that in this case the probe is
likely present in the surface of the particles (as opposed to the case of
Alexa), we believe that the biodistribution obtained using Alexa680 is
probably the more reliable one, therefore this was analysed with more
detail.
Analysing Fig. 5.Ia, we could see that animals administered with
nanogel exhibited higher ﬂuorescence intensity at all time points, as
compared to native HyA and Alexa680. In fact, 8 h after administration,
free Alexa680 has almost fully cleared from animals and native HyA has
taken an abrupt reduction. To further investigate sample biodistribu-
tion, we collected mice whole blood and major organs – spleen, heart,
kidneys, lungs, liver, skin, muscle and brain – which were analysed ex
vivo by NIRF spectroscopy (Fig. 5.Ib), since whole body images may be
misleading (Choi et al., 2010; Choi et al., 2011; Yoon et al., 2013).
The results revealed that, 48 h after administration, only nanogel
treated mice exhibited ﬂuorescence in all organs, including the blood.
As described by others (Ogawa et al., 2009), Alexa Fluor is a small,
neutral molecule that doesn't accumulate in any speciﬁc organ and is
quickly eliminated from the body. A similar behaviour was observed in
native HyA labelled samples. Indeed, after only 1 h, HyA and free
Alexa680 samples were almost extinguished. Researchers (Fraser et al.,
1984; Necas et al., 2008) have described that native HyA half-life
ranged between 2.5 and 5.5 min. Also, described that its elimination
predominantly by the kidneys, being the upper molecular weight limit
for renal excretion, 25,000 Da. In turn, nanogel was concentrated in
major organs, especially in the liver and kidneys, presumably in the
reticuloendothelial system. Also, It has been demonstrated that (Kumar
et al., 2010) smaller sized nanoparticles can be eﬀectively cleared from
body by renal excretion. Larger sized particles are processed by the
reticuloendothelial system in the liver and kidneys. Nanogel has a
bimodal size distribution, bearing two populations with ~30 nm and
~200 nm, therefore it is not surprising that the nanogel is being ﬁltered
in the kidneys and internalized by macrophages in the liver (Choi et al.,
2010; Arami et al., 2015). In addition, being made of hyaluronic acid,
the nanogel is probably also digested by hyaluronidases to some extent.
5.3. Biodistribution proﬁle of nanogel in tumor xenograft models
Understanding the in vivo biodistribution of nanogel, especially in
disease animal models, is essential for the design and eﬀective
biomedical application of nanomedicines (Choi et al., 2010). Real-time
NIRF images of nanogel and native HyA labelled with Alexa680, were
assessed in A549 tumor-bearing mice, over the course of 48 h. In vitro
results demonstrated higher recognition and uptake of the HyA nanogel
by A549 cells, which overexpress CD44 receptors. Therefore, we
evaluated the HyA receptors targeting in mice subcutaneously induced
with A549 tumor (Ganesh et al., 2013; Hwang et al., 2008).
As expected, initially a strong NIR signal was observed throughout
Fig. 3. Confocal analysis of A549 and CFBE cells exposed to HyA-AT-ﬂuorescein nanogel at 0.2 mg/ml concentration. Competitive study of nanogel internalization by pre-incubating
A549 cells with free HyA. Cells were stained with DAPI (blue) for the cell nucleus and Fluorescein (green) is credited to nanogel. Images are presented as a projection of all images
acquired in a Z stack. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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the body (Fig. 6.I), in the major organs and blood (Fig. 6.II) after
administration of both nanogel and native HyA samples. As expected,
and as observed in the case of the healthy animals, liver was the major
clearance organ. Only 5 min after administration, NIR images revealed
similar distribution for nanogel and HyA, namely in tumor tissue. In
turn, 1 h post-administration, the free polymer signal decreased notice-
ably in all organs and largely in the tumor, while the nanogel
concentrated over the ﬁrst hour at tumor site (Fig. 6.V). Around 8 h
post-administration it was noticeable that almost all traces of HyA were
eliminated. However, at that time point, the nanogel remained detect-
able in the tumor, exhibiting a strong signal. This eﬀect may be due to a
combination of two factors; receptor mediated targeting through CD44
and enhanced permeation and retention (EPR) (Ganesh et al., 2013;
Leung et al., 2010; Whitmire et al., 2012; Bartlett et al., 2007; Yhee
Fig. 4. Schematic representation of HyA-AT nanogel labelled with Cy5.5 (IA) and Alexa680 (IIA). B) Hydrodynamic diameter of labelled nanogels was determined by DLS. C) Excitation
spectra of 4× diluted HyA-AT-Cy5.5 and HyA-AT-Alexa680 samples.
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Fig. 5. Section I: In vivo biodistribution proﬁle of nanogel labelled with Alexa680, in healthy mice. a) Fluorescence intensity images of mice whole body. b) ex vivo imaging of major
organs and whole blood. c) Average ﬂuorescence intensity from excised organs of HyA treated mice. d) Average ﬂuorescence intensity from excised organs of nanogel treated mice. e)
Average ﬂuorescence intensity from excised organs of Alexa680 treated mice. f) Average ﬂuorescence intensity from excised organs, 48 h after samples administration. Comparative
analysis. g) Average ﬂuorescence intensity from whole blood, through time in all samples. Section II: In vivo pharmacokinetics of Cy5.5 labelled nanogel, in healthy animals. a)
Fluorescence images of mice whole body after Cy5.5 labelled nanogel and HyA administration. b) ex vivo imaging of ﬂuorescence intensity in major organs and blood after administration
of Cy5.5 labelled samples. c) Average ﬂuorescence intensity of excised organs, 48 h after Cy5.5 labelled samples administration. d) Blood average ﬂuorescence intensity through time, in
Cy5.5 labelled samples. Data are shown as mean ± SD, n= 5.
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Fig. 6. In vivo biodistribution proﬁle of HyA-AT nanogel in A549 tumor bearing mice. I) Fluorescence intensity images of mice whole body. Arrows indicate the tumor mass localization.
Images were acquired with mice in dorsal (left) and ventral position (right). II) ex vivo imaging of major organs, tumor mass and whole blood. IIIa) Average ﬂuorescence intensity from
excised organs of nanogel treated mice. IIIb) Average ﬂuorescence intensity from excised organs of HyA treated mice. IV) Average ﬂuorescence intensity from whole blood over time in all
samples. V) Average ﬂuorescence intensity in tumor mass over time in all samples. Data are shown as mean ± SD, n= 5.
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et al., 2014). Also, the fact that nanogel continued to be detected in
circulation up to 48 h (Fig. 6.II and .IV) it is expected to allow higher
tumor targetability. The increased blood circulation half-life, as well as
the longer residence time in the tumor tissue as compared to the native
hyaluronic acid, is probably due to the lower degradability owing to the
chemical modiﬁcation. Ganesh et al., also described in vivo high tumor
targetability in A549 cell lines (Ganesh et al., 2013), using cisplatin
loaded CD44 targeted hyaluronic acid nanoparticles. Photo-crosslinked
hyaluronic acid nanoparticles (Yoon et al., 2013) and hyaluronic acid
nanoparticles (Choi et al., 2010) also demonstrated hyaluronic acid
targetability to SCC7 cancer cells, also CD44 overexpressing cells.
6. Conclusion
Hyaluronic acid nanogel showed in vitro and in vivo targetability
towards HyA receptors, probably associated with CD44 receptors. In
vitro studies revealed higher cellular uptake by CD44 overexpressing
lung cancer cells. Also, in vivo reports showed selective targeting
towards tumor tissue, probably due to both passive accumulation
through EPR eﬀect and active targeting by HyA receptor aﬃnity. It is
described that nanomaterials behaviour in vivo, namely its pharmaco-
kinetics, is inﬂuenced by size, shape and surface characteristics; in this
work we wanted to observe the inﬂuence of the NIR probe used for
biodistribution studies. The most studied probe in NIR imaging is
Cy5.5. Therefore, we wanted to compare the pharmacokinetics proﬁle
of nanogel labelled with Cy5.5 and Alexa680 with similar excitation
and emission wavelength. Our results showed that organ accumulation
was diﬀerent in nanogel labelled with Cy5.5 and Alexa680. Further
work, regarding the protein corona of labelled nanogel is necessary to
understand the diﬀerences in pharmacokinetics proﬁles. In conclusion,
results show that HyA-AT nanogel can be used for active tumor
targeting, as a drug delivery system, optical imaging agent and others.
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